Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection

NCT: NCT05300464 · RECRUITING

NCT IDNCT05300464
StatusRECRUITING
Start Date2023-01-07
Completion2027-01-31

Brief Summary

This is a multicentric, single arm, prospective, stratified by breast density clinical investigation to confirm the ability of the microwave mammogram 'MammoWave' to detect breast lesions. MammoWave is a innovative medical device, class IIa marked CE, which uses microwaves instead of ionazing radiation (x-ray) for breast lesions. Specifically MammoWave employs a novel technique wich generates images by processing very low power (\<1mW) microwave. The MammoWave exam takes few minutes for breast and is performed with the patient lying in a confortable facing down position. MammoWave is safe to be used at any age, in any condition (pregnancy, specific illness and for unlimited number of times.

Frequently Asked Questions

What is A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection?

A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection is a clinical trial registered under NCT05300464. Current status: RECRUITING.

What is the status of NCT05300464?

The current status of NCT05300464 (A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection) is: RECRUITING.

When did A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection start?

A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection started on 2023-01-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.